Mutasem Omar Taha (Mutasem Taha, Mutasem O Taha)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

RSC advances

Zeitschrift fur Naturforschung. C, Journal of biosciences

Journal of molecular recognition : JMR

Vaccines

The University of Jordan

Loughborough University Faculty of Science (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

The University of Jordan Aug 23 1998

Jordan

Academic Staff - Professor :: Faculty of Pharmacy

Education History

Loughborough University Faculty of Science Oct 05 1994 - Jul 10 1998

United Kingdom

PHD :: Department of Chemistry

Loughborough University Faculty of Science Oct 04 1993 - Oct 04 1994

United Kingdom

MSC :: Department of Chemistry

The University of Jordan Oct 02 1987 - Oct 04 1992

Jordan

BSC

Publications

Mustafa M El-Abadelah, Ahmad H Abdullah, Jalal A Zahra, Salim S Sabri, Sanaa K Bardaweel, Mutasem Omar Taha
Synthesis and antitumor activity of model cyclopentene-[ g ]annelated isoindigos. Zeitschrift fur Naturforschung. C, Journal of biosciences 79 (1-2) (2024)
Mustafa M El-Abadelah, Ahmad H Abdullah, Jalal A Zahra, Salim S Sabri, Sanaa K Bardaweel, Mutasem Omar Taha
Synthesis and antitumor activity of model cyclopentene-[ g ]annelated isoindigos. Zeitschrift fur Naturforschung. C, Journal of biosciences 79 (1-2) (2024)
Mustafa M El-Abadelah, Ahmad H Abdullah, Jalal A Zahra, Salim S Sabri, Sanaa K Bardaweel, Mutasem Omar Taha
Synthesis and antitumor activity of model cyclopentene-[ g ]annelated isoindigos. Zeitschrift fur Naturforschung. C, Journal of biosciences (2024)
Husam Nassar, Wolfgang Sippl, Rana Abu Dahab, Mutasem Omar Taha
Molecular docking, molecular dynamics simulations and in vitro screening reveal cefixime and ceftriaxone as GSK3β covalent inhibitors. RSC advances 13 (17) (2023)
Nour Jamal Jaradat, Walhan Mohammad Alshaer, Mamon Hatmal, Mutasem Omar Taha
Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning. RSC advances 13 (7) (2023)
Nour Jamal Jaradat, Walhan Mohammad Alshaer, Mamon Hatmal, Mutasem Omar Taha
Discovery of new STAT3 inhibitors as anticancer agents using ligand-receptor contact fingerprints and docking-augmented machine learning. RSC advances 13 (7) (2023)
Alaa Abudayah, Safa Daoud, Mahmoud A Al-Sha'er, Mutasem Omar Taha
Pharmacophore Modeling of Targets Infested with Activity Cliffs via Molecular Dynamics Simulation Coupled with QSAR and Comparison with other Pharmacophore Generation Methods: KDR as Case Study. Molecular informatics 41 (11) (2022)
Ma'mon M Hatmal, Mohammad A I Al-Hatamleh, Amin N Olaimat, Rohimah Mohamud, Mirna Fawaz, Elham T Kateeb, Omar K Alkhairy, Reema F Tayyem, Mohamed Lounis, Marwan Al-Raeei, Rasheed K Dana, Hamzeh J Al-Ameer, Mutasem Omar Taha, Khalid M Bindayna
Reported Adverse Effects and Attitudes among Arab Populations Following COVID-19 Vaccination: A Large-Scale Multinational Study Implementing Machine Learning Tools in Predicting Post-Vaccination Adverse Effects Based on Predisposing Factors. Vaccines 10 (3) (2022)
Lubabah A Mousa, Ma'mon M Hatmal, Mutasem Omar Taha
Exploiting activity cliffs for building pharmacophore models and comparison with other pharmacophore generation methods: sphingosine kinase 1 as case study. Journal of computer-aided molecular design 36 (1) (2022)
Mahmoud A Al-Sha'er, Haneen A Basheer, Mutasem Omar Taha
Discovery of new PKN2 inhibitory chemotypes via QSAR-guided selection of docking-based pharmacophores. Molecular diversity (2022)
Shada J Alabed, Malek Zihlif, Mutasem Omar Taha
Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning. RSC advances 12 (55) (2022)
Omar Abuyaman, Ma'mon M Hatmal, Nawal S Hijjawi, Ahmad A Deeb, Mohammad Abuothman, Mutasem Omar Taha
Vitamin B12 binding to mutated human transcobalamin, in-silico study of TCN2 alanine scanning and ClinVar missense mutations/SNPs. Journal of biomolecular structure & dynamics (2022)
Mai Fayiz Al-Tawil, Safa Daoud, Ma'mon M Hatmal, Mutasem Omar Taha
Discovery of new Cdc2-like kinase 4 (CLK4) inhibitors via pharmacophore exploration combined with flexible docking-based ligand/receptor contact fingerprints and machine learning. RSC advances 12 (17) (2022)
Shada J Alabed, Malek Zihlif, Mutasem Omar Taha
Discovery of new potent lysine specific histone demythelase-1 inhibitors (LSD-1) using structure based and ligand based molecular modelling and machine learning. RSC advances 12 (55) (2022)
Majd S Hijjawi, Reem Fawaz Abutayeh, Mutasem Omar Taha
Structure-Based Discovery and Bioactivity Evaluation of Novel Aurora-A Kinase Inhibitors as Anticancer Agents via Docking-Based Comparative Intermolecular Contacts Analysis (dbCICA). Molecules (Basel, Switzerland) 25 (24) (2020)
Ma'mon M Hatmal, Walhan Mohammad Alshaer, Mohammad A I Al-Hatamleh, Malik Hatmal, Othman Smadi, Mutasem Omar Taha, Ayman J Oweida, Jennifer C Boer, Rohimah Mohamud, Magdalena Plebanski
Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2. Cells 9 (12) (2020)
Lina A Dahabiyeh, Yasser Bustanji, Mutasem Omar Taha
The herbicide quinclorac as potent lipase inhibitor: Discovery via virtual screening and in vitro/in vivo validation. Chemical biology & drug design 93 (5) (2019)
Ma'mon M Hatmal, Mutasem Omar Taha
Combining Stochastic Deformation/Relaxation and Intermolecular Contacts Analysis for Extracting Pharmacophores from Ligand-Receptor Complexes. Journal of chemical information and modeling 58 (4) (2018)
Mohammad A Khanfar, Mutasem Omar Taha
Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors. Journal of molecular recognition : JMR 30 (9) (2017)
Areej Abuhammad, Rua'a A Al-Aqtash, Brandon J Anson, Andrew D Mesecar, Mutasem Omar Taha
Computational modeling of the bat HKU4 coronavirus 3CLpro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus. Journal of molecular recognition : JMR 30 (11) (2017)

Mutasem Omar Taha.css-eqlu8i{font-size:small;padding-left:4px;} (Mutasem Taha, Mutasem O Taha)

Publication Activity (10 Years)

Top Topics

Top Venues

Mutasem Omar Taha (Mutasem Taha, Mutasem O Taha)